Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
BICYCLE THERAPEUTICS PLC entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Jefferies LLC and SVB Securities LLC (Representatives) valued at approximately $187.3 million (effective 2023-07-12).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Goldman Sachs & Co. LLC, Jefferies LLC and SVB Securities LLC (Representatives)
- Value
- approximately $187.3 million
- Effective
- 2023-07-12
Exact text from the filing
On July 12, 2023, Bicycle Therapeutics plc (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Goldman Sachs & Co. LLC, Jefferies LLC and SVB Securities LLC (the “ Representatives ”), as representatives of the several underwriters named therein (collectively, the “ Underwriters ”), pursuant to which the Company agreed to issue and sell 9,411,766 American Depositary Shares (“ ADSs ”), each representing one of the Company’s ordinary shares, nominal value £0.01 per share, and, in lieu of ADSs to investors that so choose, non-voting ordinary shares, nominal value £0.01 per share (“ Non-Voting Ordinary Shares ”), each at a public offering price of $21.25 per share (the “ Offering ”). The net proceeds to the Company from the Offering are expected to be approximately $187.3 million
View on SEC.gov